Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera

Yasmin Elbermawy, Sara EL-Desouky, Reem K Arafa, Sara Elfarrash, Ahmad Bassiouny · 2025

Read Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera by Yasmin Elbermawy, Sara EL-Desouky, Reem K Arafa, Sara Elfarrash, Ahmad Bassiouny (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743692.txt.

Description

Yasmin Elbermawy and four co-authors wrote a 2025 study on a nanoparticle treatment tested in mice bred to develop tau disease. Tau protein clumps drive Alzheimer's disease and related disorders. Most current drugs hit only one pathway. The team combined two agents in a single silver nanoparticle made by a green synthesis route.

One agent, methylene blue, blocks tau clumping. The other, moringa extract, fights oxidation and inflammation. Mice carrying the human P301S tau mutation got the combined particles, each agent alone, or salt water, for 60 days. Particle size ran 10 to 25 nanometers, with high stability. Behavior tests, tissue stains, and protein assays tracked protection. Lab assays probed how the mix blocks a tau-shaping enzyme. The design aims for synergy against a complex disease.

Catalog record

CREATORYasmin Elbermawy, Sara EL-Desouky, Reem K Arafa, Sara Elfarrash, Ahmad Bassiouny
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12743692

Browse the full library · About the Tower of Babel